Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA202860
Max Phase: Preclinical
Molecular Formula: C32H37F2NO6
Molecular Weight: 479.61
Molecule Type: Small molecule
Associated Items:
ID: ALA202860
Max Phase: Preclinical
Molecular Formula: C32H37F2NO6
Molecular Weight: 479.61
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)C(=O)O.O[C@H](CCc1ccccc1)CN1CCC(CCOC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
Standard InChI: InChI=1S/C30H35F2NO2.C2H2O4/c31-27-11-7-25(8-12-27)30(26-9-13-28(32)14-10-26)35-21-18-24-16-19-33(20-17-24)22-29(34)15-6-23-4-2-1-3-5-23;3-1(4)2(5)6/h1-5,7-14,24,29-30,34H,6,15-22H2;(H,3,4)(H,5,6)/t29-;/m1./s1
Standard InChI Key: XBIRPUDVQBQYMW-XXIQNXCHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 479.61 | Molecular Weight (Monoisotopic): 479.2636 | AlogP: 6.17 | #Rotatable Bonds: 11 |
Polar Surface Area: 32.70 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 9.42 | CX LogP: 6.60 | CX LogD: 4.59 |
Aromatic Rings: 3 | Heavy Atoms: 35 | QED Weighted: 0.36 | Np Likeness Score: -0.40 |
1. Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC.. (2006) Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity., 49 (5): [PMID:16509591] [10.1021/jm050766f] |
Source(1):